Abstract
Abstract: In 2001, the safety of drugs purchased from other countries, especially Canada, became a major policy issue in the United States. A political and geographical line was drawn in the sand separating Canadian and American drugs. Canadian drugs were characterized as dangerous—“a maple peril.” This article explores the practice of cross-border drug reimportation and considers the Bush and Clinton administration's policies regarding the necessary balance between drug access, affordability, and safety. This paper suggests continuity rather than change typified these policies. It connects business, economic, and political history with public policy and it aims to furnish an interdisciplinary overview of the legislative and executive branches, as well pharmaceutical firms and consumers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.